电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

PSCA 抗体

This anti-PSCA antibody is a 兔 多克隆 antibody detecting PSCA in WB, ELISA 和 IHC. Suitable for 人 和 小鼠.
产品编号 ABIN7254328
发货至: 中国

Quick Overview for PSCA 抗体 (ABIN7254328)

抗原

See all PSCA 抗体
PSCA (Prostate Stem Cell Antigen (PSCA))

适用

  • 69
  • 20
  • 10
  • 2
  • 2
  • 2
人, 小鼠

宿主

  • 56
  • 11
  • 1
  • 1

克隆类型

  • 58
  • 11
多克隆

标记

  • 39
  • 7
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PSCA antibody is un-conjugated

应用范围

  • 54
  • 19
  • 15
  • 13
  • 13
  • 10
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • 产品特性

    Polyclonal Antibody

    纯化方法

    Antigen affinity purification

    免疫原

    Synthetic peptide of human PSCA

    亚型

    IgG
  • 应用备注

    WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    0.78 mg/mL

    缓冲液

    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C

    储存方法

    Store at -20°C. Avoid freeze / thaw cycles.
  • 抗原

    PSCA (Prostate Stem Cell Antigen (PSCA))

    别名

    PSCA

    背景

    PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40 % of primary prostate cancers and in as many as 100 % of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.

    分子量

    Observed_MW: Refer to figures

    Calculated_MW: 13 kDa

    UniProt

    O43653
You are here:
Chat with us!